One need to learn that averages do not work here ..as well as 5x Revenue source is irrelevant for Botanix
if you state a number make better research and do not offer 5x metric valuation which mixes some unknown US Genome companies with Biotech..
you aim is to shoot down valuation considerably and make readers believe it ..
1. You Exaggerated first 2 month of Revenue , by using dividing by annual sales number by 12 >>> this I call set High & wrong expectation..this will make Q1 Revenue which company report e.g. 3 to 4mln like a disaster compared to your suggested average of 12 months! You ignore rump up and I have been beating you on this point....
2. Same on 5x - totally wrong mix up references..
you can only offer ..remain grounded and chill pill..
what will be your cohort next spin ?
BOT Price at posting:
50.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)